Our federal lawmakers should substantial and sustained investments for Alzheimer’s research funding and the dementia public ...

To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved ...

This is a pivotal moment, said Paul Aisen, M.D., founding director of ATRI. We're now on a course toward prevention, with ...

To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved Alzheimer’s disease drugs are too small to justify the costs. Neither Kisunla ...

Bill Gates is speaking out about his personal experience with Alzheimer’s — and his hope for progress in fighting the disease ...

The agency maintains that the beta-amyloid-targeting drugs show too limited benefit to justify their cost to the National Health Service.

A newly approved Alzheimer’s drug is set to be administered for the first time in Taiwan on Monday, Far Eastern Memorial Hospital in New Taipei City announced yesterday. Kisunla, the brand name of the ...

And other biotech news brought to you by The Readout.

Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...

New da­ta on an in­jectable form of Ei­sai’s Alzheimer’s drug, Leqem­bi, showed that it was more ef­fec­tive than an in­tra­venous ver­sion at clear­ing amy­loid but … ...

TAIPEI (Taiwan News) — Far Eastern Memorial Hospital is set to become the first medical institution in Taiwan to administer ...